文摘
In investigating the agonist binding site of the human brain cholecystokininB receptor (CCKBR),we employed the direct protein chemical approach using a photoreactive tritiated analogue of sulfatedcholecystokinin octapeptide, which contains the p-benzoylbenzoyl moiety at the N-terminus, followed bypurification of the affinity-labeled receptor to homogeneity. This probe bound specifically, saturably, andwith high affinity (KD = 1.2 nM) to the CCKBR and has full agonistic activity. As the starting materialfor receptor purification, we used stably transfected HEK 293 cells overexpressing functional CCKBR.Covalent labeling of the WGA-lectin-enriched receptor revealed a 70-80 kDa glycoprotein with a proteincore of about 50 kDa. Identification of the agonist binding site was achieved by the application of subsequentchemical and enzymatical cleavage to the purified receptor. A radiolabeled peptide was identified byEdman degradation amino acid sequence analysis combined with MALDI-TOF mass spectrometry. Theposition of the radioactive probe within the identified peptide was determined using combined tandemelectrospray mass spectrometry and peptide mapping. The probe was covalently attached within thesequence L52ELAIRITLY61 that represents the transition between the N-terminal domain and predictedtransmembrane domain 1. Using this interaction as a constraint to orientate the ligand within the putativereceptor binding site, a model of the CCK-8s-occupied CCKBR was constructed. The hormone was foundto be placed in a binding pocket built from both extracellular and transmembrane domains of CCKBRwith its N-terminus mainly interacting with residues Arg57 and Tyr61.